UK markets open in 3 hours 44 minutes

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
129.32-1.95 (-1.49%)
At close: 4:00PM EDT
129.35 +0.03 (0.02%)
After hours: 06:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
323,651
286,730
214,375
90,639
49,842
Cost of revenue
108,268
92,535
70,720
43,210
31,618
Gross profit
215,383
194,195
143,655
47,429
18,224
Operating expenses
Research development
195,759
149,862
86,292
50,714
25,562
Selling general and administrative
390,547
299,283
139,734
89,657
69,274
Total operating expenses
586,306
449,145
226,026
140,371
94,836
Operating income or loss
-370,923
-254,950
-82,371
-92,942
-76,612
Interest expense
6,034
4,766
1,181
1,251
2,702
Total other income/expenses net
1,032
3,641
88
4,702
-6,134
Income before tax
-369,124
-245,904
-69,723
-84,225
-83,214
Income tax expense
524
379
-1,872
38
7
Income from continuing operations
-369,648
-246,283
-67,851
-84,263
-83,221
Net income
-378,648
-253,783
-75,651
-85,063
-83,221
Net income available to common shareholders
-378,648
-253,783
-75,651
-85,063
-88,995
Basic EPS
-
-2.60
-0.84
-2.80
-1.54
Diluted EPS
-
-2.60
-0.84
-2.80
-1.54
Basic average shares
-
97,504
90,597
30,403
57,782
Diluted average shares
-
97,504
90,597
30,403
57,782
EBITDA
-
-225,073
-54,933
-75,838
-75,306